Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Cardiotoxicity 14Breast Neoplasms 10Neoplasms 4Heart Failure 4Heart Diseases 2Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Ventricular Dysfunction 1Thoracic Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Metabolic Syndrome 1Memory Disorders 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hereditary Breast and Ovarian Cancer Syndrome 1Dyspnea 1Dyslipidemias 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Cardiomyopathies 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Bone Neoplasms 1Atherosclerosis 1

Interventions

Cyclophosphamide 220Rituximab 189fludarabine phosphate 169fludarabine 102Peripheral Blood Stem Cell Transplantation 100Mycophenolic Acid 94Whole-Body Irradiation 81Tacrolimus 72Filgrastim 69Cyclosporine 67Lenalidomide 66ibrutinib 63Busulfan 61Melphalan 58Antilymphocyte Serum 57Radiotherapy 52venetoclax 48Etoposide 47obinutuzumab 42Bendamustine Hydrochloride 42Alemtuzumab 41Methotrexate 39ofatumumab 28sargramostim 27Granulocyte Colony-Stimulating Factor 26Cytarabine 26Cord Blood Stem Cell Transplantation 26acalabrutinib 25Stem Cell Transplantation 24Specimen Handling 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Lymphocytic, Chronic, B-Cell × Echocardiography × Clear all
NCT05521178 2024-10-15

Cardiotoxicities in Patients Receiving BTKi

Dana-Farber Cancer Institute

Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡